| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
interleukin 6 | 0.248 | 0.962 | 0.32 |
|
group | 0.400 | None | 1.000 | 12 | 0 | 1994 | 2019 | ||||||||
|
transforming growth factor beta 1 | 0.287 | 0.962 | 3.7E-02 |
|
group | 0.400 | None | 1.000 | 11 | 0 | 1998 | 2015 | ||||||||
|
Kruppel like factor 6 | 0.501 | 0.846 | 0.98 |
|
group | 0.400 | None | 1.000 | 11 | 0 | 2001 | 2013 | ||||||||
|
prostaglandin-endoperoxide synthase 2 | 0.314 | 0.962 | 1.00 |
|
group | 0.400 | None | 1.000 | 11 | 0 | 2000 | 2018 | ||||||||
|
glutathione S-transferase pi 1 | 0.383 | 0.923 | 1.4E-02 |
|
group | 0.400 | None | 1.000 | 11 | 0 | 2001 | 2017 | ||||||||
|
cyclin dependent kinase inhibitor 1B | 0.409 | 0.769 | 0.62 |
|
group | 0.400 | None | 1.000 | 11 | 0 | 1997 | 2018 | ||||||||
|
erb-b2 receptor tyrosine kinase 2 | 0.328 | 0.923 | 6.0E-03 |
|
group | 0.400 | None | 1.000 | 11 | 0 | 1997 | 2017 | ||||||||
|
hypoxia inducible factor 1 subunit alpha | 0.327 | 0.923 | 0.98 |
|
group | 0.400 | None | 1.000 | 11 | 0 | 2002 | 2019 | ||||||||
|
C-X-C motif chemokine ligand 12 | 0.379 | 0.846 | 0.12 |
|
group | 0.400 | None | 1.000 | 10 | 0 | 2002 | 2012 | ||||||||
|
elaC ribonuclease Z 2 | 0.670 | 0.346 | 1.7E-20 |
|
group | 0.400 | None | 1.000 | 10 | 0 | 2001 | 2008 | ||||||||
|
estrogen receptor 2 | 0.400 | 0.923 | 4.5E-08 |
|
group | 0.400 | None | 1.000 | 10 | 0 | 2002 | 2015 | ||||||||
|
enhancer of zeste 2 polycomb repressive complex 2 subunit | 0.376 | 0.885 | 1.00 |
|
group | 0.400 | None | 1.000 | 9 | 0 | 2002 | 2017 | ||||||||
|
matrix metallopeptidase 9 | 0.305 | 0.923 | 1.9E-17 |
|
group | 0.400 | None | 1.000 | 8 | 0 | 2002 | 2017 | ||||||||
|
epidermal growth factor | 0.357 | 0.923 | 8.5E-17 |
|
group | 0.400 | None | 1.000 | 8 | 0 | 1990 | 2009 | ||||||||
|
C-X-C motif chemokine ligand 8 | 0.310 | 0.962 | 2.7E-04 |
|
group | 0.400 | None | 1.000 | 8 | 0 | 2003 | 2014 | ||||||||
|
BCL2 apoptosis regulator | 0.291 | 0.885 | 0.56 |
|
group | 0.400 | None | 1.000 | 7 | 0 | 1999 | 2018 | ||||||||
|
caveolin 1 | 0.388 | 0.885 | 8.3E-03 |
|
group | 0.400 | None | 1.000 | 7 | 0 | 2002 | 2019 | ||||||||
|
MYC proto-oncogene, bHLH transcription factor | 0.344 | 0.923 | 1.00 |
|
group | 0.400 | None | 1.000 | 6 | 0 | 2005 | 2018 | ||||||||
|
signal transducer and activator of transcription 3 | 0.320 | 0.923 | 1.00 |
|
group | 0.400 | None | 1.000 | 6 | 0 | 2002 | 2019 | ||||||||
|
clusterin | 0.426 | 0.885 | 7.8E-05 |
|
group | 0.400 | None | 1.000 | 6 | 0 | 1996 | 2019 | ||||||||
|
BRCA1 DNA repair associated | 0.367 | 0.923 | 9.2E-29 |
|
group | 0.400 | None | 1.000 | 5 | 0 | 1998 | 2013 | ||||||||
|
folate hydrolase 1 | 0.453 | 0.885 | 6.2E-09 |
|
group | 0.400 | None | 1.000 | 3 | 0 | 1997 | 2020 | ||||||||
|
early growth response 1 | 0.433 | 0.923 | 0.35 |
|
group | 0.400 | None | 1.000 | 3 | 0 | 2002 | 2013 | ||||||||
|
ETS variant transcription factor 1 | 0.631 | 0.385 | 0.94 |
|
group | 0.390 | None | 1.000 | 5 | 0 | 2007 | 2016 | ||||||||
|
parathyroid hormone like hormone | 0.453 | 0.846 | 0.81 |
|
group | 0.390 | None | 1.000 | 3 | 0 | 1999 | 2013 |